Patient derived organoids reveal that PI3K/AKT signaling is an escape pathway for radioresistance and a target for therapy in rectal cancer.
K. Wanigasooriya, J. D. Barros-Silva, L. Tee, M. E. Elasrag, A. Stodolna, O. Pickles, J. D. Stockton, C. Bryer, R. Hoare, C. M. Whalley, R. Tyler, T. Sillo, C. Yau, T. Ismail, A. D. Beggs
The paper identifies PI3K/AKT/mTOR pathway upregulation as a mechanism of radioresistance in rectal cancer and shows that dual PI3K/mTOR inhibitors radiosensitize cancer cells in organoid models.
bioRxiv · Aug 31, 2021 · PreprintCancer Biology